...
首页> 外文期刊>Journal of Leukocyte Biology: An Official Publication of the Reticuloendothelial Society >Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes
【24h】

Common and biased signaling pathways of the chemokine receptor CCR7 elicited by its ligands CCL19 and CCL21 in leukocytes

机译:趋化因子受体CCR7的配体CCL19和CCL21在白细胞中引发的常见和偏向信号通路

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Chemokines are pivotal regulators of cell migration during continuous immune surveillance, inflammation, homeostasis, and development. Chemokine binding to their 7-transmembrane domain, G-protein-coupled receptors causes conformational changes that elicit intracellular signaling pathways to acquire and maintain an asymmetric architectural organization and a polarized distribution of signaling molecules necessary for directional cell migration. Leukocytes rely on the interplay of chemokine-triggered migration modules to promote amoeboid-like locomotion. One of the most important chemokine receptors for adaptive immune cell migration is the CC-chemokine receptor CCR7. CCR7 and its ligands CCL19 and CCL21 control homing of T cells and dendritic cells to areas of the lymph nodes where T cell priming and the initiation of the adaptive immune response occur. Moreover, CCR7 signaling also contributes to T cell development in the thymus and to lymphorganogenesis. Although the CCR7-CCL19/CCL21 axis evolved to benefit the host, inappropriate regulation or use of these proteins can contribute or cause pathobiology of chronic inflammation, tumorigenesis, and metastasis, as well as autoimmune diseases. Therefore, it appears as the CCR7-CCL19/CCL21 axis is tightly regulated at numerous intersections. Here, we discuss the multiple regulatory mechanism of CCR7 signaling and its influence on CCR7 function. In particular, we focus on the functional diversity of the 2 CCR7 ligands, CCL19 and CCL21, as well as on their impact on biased signaling. The understanding of the molecular determinants of biased signaling and the multiple layers of CCR7 regulation holds the promise for potential future therapeutic intervention.
机译:趋化因子是持续免疫监测,炎症,体内平衡和发育过程中细胞迁移的关键调节剂。趋化因子结合到它们的7个跨膜结构域,G蛋白偶联受体引起构象变化,该构象变化引发细胞内信号传导途径,以获取并维持不对称的结构组织和方向性细胞迁移所必需的信号分子的极化分布。白细胞依靠趋化因子触发的迁移模块的相互作用来促进类阿米巴样运动。 CC趋化因子受体CCR7是适应性免疫细胞迁移最重要的趋化因子受体之一。 CCR7及其配体CCL19和CCL21控制着T细胞和树突状细胞向着T细胞启动和适应性免疫应答发生的淋巴结区域的归巢。此外,CCR7信号转导也有助于胸腺中的T细胞发育和淋巴器官形成。尽管CCR7-CCL19 / CCL21轴进化为对宿主有益,但这些蛋白质的不适当调节或使用可能会导致或引起慢性炎症,肿瘤发生和转移以及自身免疫性疾病的病理生物学。因此,CCR7-CCL19 / CCL21轴在许多交叉点都受到严格调节。在这里,我们讨论了CCR7信号的多重调控机制及其对CCR7功能的影响。特别地,我们关注2个CCR7配体CCL19和CCL21的功能多样性,以及它们对有偏向的信号传导的影响。对有偏向的信号传导的分子决定因素和CCR7调控的多层性的理解为将来可能的治疗干预提供了希望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号